The Complete Requirements Checklist to Get Spinraza (Nusinersen) Covered by Blue Cross Blue Shield in New York
Answer Box: Your Path to Spinraza Coverage
Who qualifies: Patients with genetically confirmed 5q SMA (Types 1-3) who haven't received concurrent SMA therapies like Zolgensma or Evrysdi. Fastest approval path: Submit prior authorization with genetic testing results, baseline motor function scores, and neurologist attestation through your Blue Cross